The gist: Presently and primarily in younger males with the second dose, there appears to be a small increase in the risk of myocarditis with mRNA vaccination. This is definitely not a trivial matter and it needs to be taken seriously, but the concerns need to be weighed against the risks of COVID-19. To start with, COVID-19 is itself a known cause of myocarditis, and even if we take 12-17 year-old-males and the second dose of mRNA vaccine as a point of reference (available data suggest this ...
